Bibliography (19):

1. https://clinicaltrials.gov/ct2/show/NCT04451837

2. Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial

3. Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomized, double-blind, phase 3a trial

4. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

5. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomized, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

6. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes [SURPASS-2]

7. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

8. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials

9. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

10. Wikipedia Bibliography:

    1. https://en.wikipedia.org/wiki/Diabetes_medication  :

       https://en.wikipedia.org/wiki/Diabetes_medication

    2. Type 2 diabetes

    3. https://en.wikipedia.org/wiki/GLP-1_receptor_agonist  :

       https://en.wikipedia.org/wiki/GLP-1_receptor_agonist

    4. Semaglutide

    5. https://en.wikipedia.org/wiki/SGLT2_inhibitor  :

       https://en.wikipedia.org/wiki/SGLT2_inhibitor

    6. https://en.wikipedia.org/wiki/Dapagliflozin  :

       https://en.wikipedia.org/wiki/Dapagliflozin

    7. Glycated hemoglobin

    8. Confidence interval

    9. Statistical-significance

    10. Body mass index